URGN – urogen pharma ltd. - ordinary shares (US:NASDAQ)

News

UroGen Applauds BCAN's New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence [Yahoo! Finance]
UroGen Applauds BCAN’s New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
UroGen Weighs ENVISION Success And Expanded Loan In Bladder Cancer Push [Yahoo! Finance]
UroGen: ZUSDURI Poised To Replace TURBT Surgery As SOC In Certain Bladder Cancers [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com